Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IVZ · NYSE · Asset Management & Custody Banks
$28.65−0.29 (−1.00%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Invesco (IVZ) · oqro.io/stocks/IVZ · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Sep 11, 2026 · Filed Sep 14, 2026
Director sold ~$97K of IVZ shares in the open marketSourcePlanned sale · Planned for Sep 11, 2026 · Notice filed Sep 11, 2026
Director filed to sell about $97K of IVZ stockSourceInsider trade · Traded Sep 9, 2026 · Filed Sep 10, 2026
Officer sold ~$3.25M of IVZ shares in the open marketSourceInsider trade · Traded Sep 9, 2026 · Filed Sep 10, 2026
Officer sold ~$1.46M of IVZ shares in the open marketSourceInsider trade · Traded Sep 8, 2026 · Filed Sep 10, 2026
Officer sold ~$1.4M of IVZ shares in the open marketSourceInsider trade · Traded Sep 4, 2026 · Filed Sep 9, 2026
CFO sold ~$1.03M of IVZ shares in the open marketSourcePlanned sale · Planned for Sep 9, 2026 · Notice filed Sep 9, 2026
Officer filed to sell about $3.25M of IVZ stockSourcePlanned sale · Planned for Sep 9, 2026 · Notice filed Sep 9, 2026
Officer filed to sell about $1.46M of IVZ stockSourcePlanned sale · Planned for Sep 8, 2026 · Notice filed Sep 8, 2026
Officer filed to sell about $1.4M of IVZ stockSourcePlanned sale · Planned for Sep 4, 2026 · Notice filed Sep 8, 2026
Officer filed to sell about $1.03M of IVZ stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Letko, Brosseau & Associates Inc disclosed a reduced position in IVZ for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 4, 2026
Todd Asset Management LLC disclosed a reduced position in IVZ for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 10, 2026
Wedge Capital Management L L P disclosed a reduced position in IVZ for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates no longer reported IVZ for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Samlyn Capital, LLC no longer reported IVZ for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Todd Asset Management LLC disclosed a new position in IVZ for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Letko, Brosseau & Associates Inc disclosed a reduced position in IVZ for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 13, 2026
Wedge Capital Management L L P disclosed a reduced position in IVZ for Q1 2026SourcePolitician trade (House) · Transaction Mar 17, 2026 · Disclosed Apr 3, 2026
Disclosed sale of IVZ — reported range $15,001 - $50,000SourcePolitician trade (House) · Transaction Feb 10, 2026 · Disclosed Mar 9, 2026
Disclosed partial sale of IVZ — reported range $1,001 - $15,000SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Samlyn Capital, LLC disclosed an increased position in IVZ for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a reduced position in IVZ for Q4 2025SourcePolitician trade (House) · Transaction Jan 9, 2026 · Disclosed Feb 13, 2026
Disclosed purchase of IVZ — reported range $1,001 - $15,000SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
Letko, Brosseau & Associates Inc disclosed a reduced position in IVZ for Q4 2025Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 14, 2026
Wedge Capital Management L L P disclosed a new position in IVZ for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Samlyn Capital, LLC disclosed a new position in IVZ for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Bridgewater Associates disclosed a new position in IVZ for Q3 2025SourceInsider trade · Traded Oct 31, 2025 · Filed Nov 3, 2025
Officer sold ~$3.77M of IVZ shares in the open marketSourceInsider trade · Traded Sep 10, 2025 · Filed Sep 12, 2025
Officer sold ~$2.28M of IVZ shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Bridgewater Associates no longer reported IVZ for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Bridgewater Associates disclosed a reduced position in IVZ for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 8, 2025
Letko, Brosseau & Associates Inc disclosed a reduced position in IVZ for Q1 2025SourcePolitician trade (House) · Transaction Apr 8, 2025 · Disclosed Apr 28, 2025
Disclosed sale of IVZ — reported range $1,001 - $15,000SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Susquehanna Portfolio Strategies, LLC no longer reported IVZ for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Letko, Brosseau & Associates Inc disclosed a reduced position in IVZ for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Bridgewater Associates disclosed a new position in IVZ for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Itau Unibanco Holding S.A. no longer reported IVZ for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Susquehanna Portfolio Strategies, LLC disclosed a reduced position in IVZ for Q3 2024SourcePolitician trade (Senate) · Transaction Oct 17, 2024 · Disclosed Nov 14, 2024
Disclosed sale of IVZ — reported range $1,001 - $15,000SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
Bridgewater Associates no longer reported IVZ for Q3 2024